Literature DB >> 7003480

Chemotherapy of head and neck cancer.

R E Wittes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7003480

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN： 0030-6665            Impact factor:   3.346


× No keyword cloud information.
  3 in total

1.  Oncolysis using herpes simplex virus type 1 engineered to express cytosine deaminase and a fusogenic glycoprotein for head and neck squamous cell carcinoma.

Authors:  Daniel L Price; Shu-Fu Lin; Ziqun Han; Guy Simpson; Robert S Coffin; Joyce Wong; Sen Li; Yuman Fong; Richard J Wong
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-02

Review 2.  Clinical trials with fluorinated pyrimidines in patients with head and neck cancer.

Authors:  M al-Sarraf
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

Review 3.  Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: a systematic review.

Authors:  Alessandro Guidi; Carla Codecà; Daris Ferrari
Journal:  Med Oncol       Date:  2018-02-13       Impact factor: 3.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.